STAT

Turn to evidence-based approaches for spending $800 million to fight opioid addiction

To quell opioid addiction, we need to rely on programs based on scientific evidence — not on anecdote, status quo, or political belief.
Source: KERRY SHERIDAN/AFP/Getty Images

The bipartisan spending agreement Congress passed earlier this year includes about $800 million to fight opioid addiction  and increase access to treatment and recovery services. This appropriation — up from $150 million in the last budget — builds on an additional $485 million in grants to states provided for in the 21st Century Cures Act.

How the government decides to spend this money could be a turning point in the opioid epidemic or mark a missed opportunity to address the crisis that’s killing tens of thousands of Americans each year.

The opioid epidemic is one and some of which are not.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related